OBR Daily Commentary

forumImage

Prostate Cancer Treatment Could Work In Half The Time And Without Gruelling Side Effects, 14-Year Study Finds

(The Telegraph [UK]) June 20, 2016 - Men with prostate cancer could undergo treatment in half the time and be spared gruelling side-effects, a major trial has found.

Read Article arrow

Howard Sandler, MD, MS, FASTRO (Posted: June 21, 2016)

quotesLancet Oncology has just published two articles on (moderate) hypofractionation for prostate cancer that suggest non-inferiority of hypofractionation. In combination with RTOG 0415 published earlier this year in JCO (Lee WR et al. J Clin Oncol. 2016 Apr 4. pii: JCO670448. [Epub ahead of print] PMID: 27044935) and with the Canadian PROFIT trial (Catton PI) presented at ASCO 2016, there is ample evidence to support moderate hypofractionation for prostate cancer. Adoption of these approaches should be done carefully with due attention to the details of the radiotherapy (IGRT, appropriate margins, etc.) and, if adopted, will provide excellent, safe care that is less expensive and more convenient for our patients.quotes

Add Comment 1 Comment
forumImage

Largest Study Of Patients With Early Stage II Testicular Cancer Shows Radiation Therapy Is More Effective Than Chemotherapy

(ESTRO 35) May 2, 2016 - A large study of testicular cancer patients has shown that radiation therapy is a better treatment than chemotherapy for patients with stage IIa disease (where one or more regional lymph nodes contain cancer cells but they are less than 2cms in diameter).

Read Article arrow

Howard Sandler, MD, MS, FASTRO (Posted: May 02, 2016)

quotesUsing NCDB, authors show that radiotherapy is superior to chemotherapy for stage IIa testicular seminoma. While stage IIa disease is relatively rare, a relatively common situation is surveillance for stage I disease, with retroperitoneal relapse with stage IIa lymphadenopathy. This study suggests that patients who relapse while on surveillance (i.e. 15% of all surveilled stage I patients) should be considered for radiotherapy at the time of relapse. RT in this situation seems to be at least as effective as chemotherapy and, in my view, is less morbid than 3 cycles of BEP chemotherapy.quotes

Add Comment 1 Comment
forumImage

UC Davis Lung Cancer Specialist Karen Kelly To Take The Reins Of Prestigious SWOG Lung Committee

(PRWEB) Nov 4, 2015 - Karen Kelly, associate director for clinical research at the UC Davis Comprehensive Cancer Center, has been named chair of the Lung Committee of SWOG, one of the nation’s leading cooperative cancer research organizations.

Read Article arrow

Howard Sandler, MD, MS, FASTRO (Posted: November 06, 2015)

quotesCongratulations to Karen Kelly as she assumes the role of Lung Committee chair. This distinguished committee will continue to perform cooperative group practice changing clinical trials!quotes

Add Comment 1 Comment

Meet the Editorial Board

Community Oncology
member photo
Dean Gesme, MD

FACP FACPE FASCO President, Minnesota Oncology...

Breast Cancer
member photo
Debu Tripathy, MD

Professor and Chair, Department of Breast Medical Oncol...

Lung Cancer
member photo
H. Jack West, MD

Medical Director, Thoracic Oncology Program, Swedish Ca...

Gastrointestinal Cancers
member photo
Howard S. Hochster, MD

Associate Cancer Center Director, Yale Cancer Center P...

Radiation Oncology
member photo
Howard Sandler, MD, MS, FASTRO

Professor and Chair, Department of Radiation Oncology...

Community Oncology
member photo
Jeff Patton, M.D.

CEO Tennessee Oncology...

Precision Medicine Section Editor
member photo
Jennifer Levin Carter, MD, MPH

Chief Medical Officer and Founder, N-of-One...

Health Policy
member photo
Joseph Bailes, MD

National Health Policy Expert...

Financial Sector
member photo
Michael G. King Jr.

Managing Director and Senior Biotechnology Analyst...

Gastrointestinal Cancers
member photo
Richard Goldberg, MD

Professor and Physician-in-Chief of the Ohios State Uni...

Editor-In-Chief
member photo
Robert A. Figlin, MD., FACP

Professor and Director, Division of Hematology Oncology...

Community Oncology
member photo
Thomas Marsland, MD

Vice President Integrated Community Oncology Network ...

Community Oncology
member photo
William Harwin MD

Florida Cancer Specialists President and Managing Part...

Health Policy
member photo
William McGivney, PhD

National Health Policy Expert...

Payer
member photo
Winston Wong, PharmD

President, W-Squared Group...